The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
Open accessAbstract
C.B-17 severe combined immune deficient (SCID) mice, which lack functional B and T lymphocytes, allow xenografts and, therefore, can be used to study the biology of human malignancies. Two different human B cell lymphoma cell lines, SU-DHL-4 and OCI-Ly8, which both harbor the t(14;18) chromosomal translocation, were injected into C.B-17 SCID mice. Mice injected intravenously or intraperitoneally developed tumors and died in a dose-dependent manner. The presence of tumor cells in various murine tissues could be demonstrated by a clonogenic tumor assay, staining of frozen sections with a monoclonal antibody (mAb) against a human B cell antigen (CD19), and with the polymerase chain reaction technique. A protocol using cytotoxic effector cells was developed and used to selectively deplete the tumor cells from bone marrow. These cells were developed by growing peripheral blood mononuclear cells in the presence of interferon gamma (IFN-gamma), anti-CD3 mAb, and interleukin 2 (IL-2). The timing of IFN-gamma treatment was critical and optimal if IFN-gamma was added before IL-2 treatment. The cells that were stimulated by IFN-gamma, followed by IL-2, could be expanded by treatment with a mAb directed against CD3. These cells could be further activated by IL-1, but not by tumor necrosis factor alpha. With this protocol, a tumor cell kill of 3 logs was obtained as measured by a clonogenic assay. Interestingly, despite their high cytotoxic activity against lymphoma cells, these cells had little toxicity against a subset of normal human hematopoietic precursor cells (granulocyte/macrophage colony-forming units). These cells were further tested by treating murine bone marrow contaminated with the human lymphoma cell line SU-DHL-4, and injecting these cells into SCID mice to assay for tumor growth in vivo. The animals injected with bone marrow contaminated with SU-DHL-4 cells had enhanced survival if the bone marrow was treated with the cytokine-induced killer cells before infusion. The SCID mouse provides a useful in vivo model for evaluation of new therapeutic approaches for lymphoma treatment. The cytokine-induced killer cells generated as described here could have an important impact on bone marrow purging for autologous bone marrow transplantation as well as for adoptive immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132327 · Cited by 2,653
A severe combined immunodeficiency mutation in the mouse
Bosma, G. C., Custer, R. P., & Bosma, M. J. (1983) · Nature · doi:10.1038/301527a0 · Cited by 2,207
Grimm, E. A., Mazumder, A., Zhang, H. Z., & Rosenberg, S. A. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.6.1823 · Cited by 2,204
A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
Rosenberg, S. A., Spiess, P., & Lafreniere, R. (1986) · Science · doi:10.1126/science.3489291 · Cited by 1,880
McCune, J., Namikawa, R., Kaneshima, H., Shultz, L., Lieberman, M., & Weissman, I. (1988) · Science · doi:10.1126/science.241.4873.1632 · Cited by 1,406
Self-citationTransfer of a functional human immune system to mice with severe combined immunodeficiency
Mosier, D. E., Gulizia, R. J., Baird, S. M., & Wilson, D. B. (1988) · Nature · doi:10.1038/335256a0 · Cited by 1,255
Alonso, S., Minty, A., Bourlet, Y., & Buckingham, M. (1986) · Journal of Molecular Evolution · doi:10.1007/bf02100994 · Cited by 643
Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency
Schuler, W., Weiler, I. J., Schuler, A., Phillips, R. A., Rosenberg, N., Mak, T. W., Kearney, J. F., Perry, R. P., & Bosma, M. J. (1986) · Cell · doi:10.1016/0092-8674(86)90695-1 · Cited by 545
Kaye, J., Gillis, S., Mizel, S. B., Shevach, E. M., Malek, T. R., Dinarello, C. A., Lachman, L. B., & Janeway, C. A. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.3.1339 · Cited by 519
Natural killer cells: definition of a cell type rather than a function
Lanier, L. L., Phillips, J. H., Hackett, J., Tutt, M., & Kumar, V (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.8.2745.a · Cited by 384
Infection of the SCID-hu Mouse by HIV-1
Namikawa, R., Kaneshima, H., Lieberman, M., Weissman, I. L., & McCune, J. M. (1988) · Science · doi:10.1126/science.3201256 · Cited by 366
Self-citationExpansion of human tumor infiltrating lymphocytes for use in immunotherapy trials
Topalian, S. L., Muul, L. M., Solomon, D., & Rosenberg, S. A. (1987) · Journal of Immunological Methods · doi:10.1016/s0022-1759(87)80018-2 · Cited by 362
Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
Dorshkind, K., Pollack, S. B., Bosma, M. J., & Phillips, R. A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.3798 · Cited by 346
Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.
Custer, R. P., Bosma, G. C., & Bosma, M. J. (1985) · PubMed · Cited by 310
A Model of Human Acute Lymphoblastic Leukemia in Immune-Deficient SCID Mice
Kamel-Reid, S., Letarte, M., Sirard, C., Doedens, M., Grunberger, T., Fulop, G., Freedman, M. H., Phillips, R. A., & Dick, J. E. (1989) · Science · doi:10.1126/science.2595371 · Cited by 236
Suppression of HIV Infection in AZT-Treated SCID-hu Mice
McCune, J. M., Namikawa, R., Shih, C.-C., Rabin, L., & Kaneshima, H. (1990) · Science · doi:10.1126/science.2300816 · Cited by 196
Itoh, K., Shiiba, K., Shimizu, Y., et al. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.5.3124 · Cited by 187
Ochoa, A. C., Gromo, G., Alter, B. J., Sondel, P. M., & Bach, F. H. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.8.2728 · Cited by 176
The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor
Tweeddale, M., Lim, B., Jamal, N., Robinson, J., Zalcberg, J., Lockwood, G. A., Minden, M., & Messner, H. (1987) · Blood · doi:10.1182/blood.v69.5.1307.1307 · Cited by 130
Murphy, M. E., PERUSSIA, B., & Trinchieri, G. (1988) · PubMed · Cited by 122
Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies.
Stall, A. M., & Loken, M. R. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.2.787 · Cited by 112
Brunda, M. J., Tarnowski, D., & Davatelis, V. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910370522 · Cited by 99
Abelson virus-induced lymphomagenesis in mice.
Risser, R., Potter, M., & Rowe, W. P. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.3.714 · Cited by 86
Reddy, S., Piccione, D., Takita, H., & Bankert, R. B. (1987) · PubMed · Cited by 83
The function of antigen-presenting cells in mice with severe combined immunodeficiency.
Czitrom, A. A., Edwards, S., Phillips, R. A., Bosma, M. J., Marrack, P., & Kappler, J. W. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.4.2276 · Cited by 72
Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
Ellis, T., McKenzie, R. S., Simms, P. E., Helfrich, B., & Fisher, R. I. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.12.4282 · Cited by 69
Tutt, M. M., Schüler, W., Kuziel, W. A., et al. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.7.2338 · Cited by 56
Hirayoshi, K., Nishikawa, S., Kina, T., Hatanaka, M., Habu, S., Nomura, T., & Katsura, Y. (1987) · European Journal of Immunology · doi:10.1002/eji.1830170723 · Cited by 27
Cited by
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
Verneris, M. R., Karami, M., Baker, J., Jayaswal, A., & Negrin, R. S. (2004) · Blood · doi:10.1182/blood-2003-06-2125 · Cited by 383
Self-citationUse of Reporter Genes for Optical Measurements of Neoplastic Disease In Vivo
Contag, C. H., Jenkins, D., Contag, P. R., & Negrin, R. S. (2000) · Neoplasia · doi:10.1038/sj.neo.7900079 · Cited by 363
Self-citationVisualizing the kinetics of tumor-cell clearance in living animals
Sweeney, T. J., Mailänder, V., Tucker, A. A., Olomu, A. B., Zhang, W., Cao, Y.-A., Negrin, R. S., & Contag, C. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12044 · Cited by 350
Self-citationImmune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation
Guillaume, T., Rubinstein, D. B., & Symann, M. (1998) · Blood · doi:10.1182/blood.v92.5.1471 · Cited by 323
Edinger, M., Cao, Y.-A., Verneris, M. R., Bachmann, M. H., Contag, C. H., & Negrin, R. S. (2003) · Blood · doi:10.1182/blood-2002-06-1751 · Cited by 308
Self-citation
Metadata
- Authors
- Schmidt-Wolf, I. G., Negrin, R. S., Kiem, H. P., Blume, K. G., & Weissman, I. L.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1991-07-01
- Volume
- 174
- Issue
- 1
- Pages
- 139-149
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2133114658
- Cited by
- 614
- References
- 29
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.